Home > Insider Trading > Filing (0001182489-15-000697)

Filing Details

Accession Number:: 0001182489-15-000697
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-09-11 16:47:53
Reporting Period:: 2015-09-09

Filing Date:: 2015-09-11
Accepted Time:: 2015-09-11 16:47:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1618561	Nexvet Biopharma Plc	NVET	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
909661	Farallon Capital Management Llc	One Maritime Plaza, Suite 2100 San Francisco CA 94111	No	No	Yes	Yes
1040153	C/Ca L L Partners Farallon	C/O Farallon Capital Management, L.l.c., One Maritime Plaza, Suite 2100 San Francisco CA 94111	No	No	Yes	Yes
1245636	R Monica Landry	C/O Farallon Capital Management, L.l.c. One Maritime Plaza, Suite 2100 San Francisco CA 94111	No	No	Yes	Yes
1245637	B Richard Fried	C/O Farallon Capital Management, L.l.c. One Maritime Plaza, Suite 2100 San Francisco CA 94111	No	No	Yes	Yes
1372968	M J Andrew Spokes	C/O Farallon Capital Management, L.l.c. One Maritime Plaza, Suite 2100 San Francisco CA 94111	No	No	Yes	Yes
1453042	Jr. G. Thomas Roberts	C/O Farallon Capital Management, L.l.c. One Maritime Plaza, Suite 2100 San Francisco CA 94111	No	No	Yes	Yes
1453077	J. Daniel Hirsch	C/O Farallon Capital Management, L.l.c. One Maritime Plaza, Suite 2100 San Francisco CA 94111	No	No	Yes	Yes
1495856	G Michael Linn	C/O Farallon Capital Management, L.l.c. One Maritime Plaza, Suite 2100 San Francisco CA 94111	No	No	Yes	Yes
1595643	T David Kim	C/O Farallon Capital Management, L.l.c. One Maritime Plaza, Suite 2100 San Francisco CA 94111	No	No	Yes	Yes
1611816	B. Michael Fisch	C/O Farallon Capital Management, L.l.c. One Maritime Plaza, Suite 2100 San Francisco CA 94111	No	No	Yes	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2015-09-09	31	$5.75	787,066	No	4	P	Direct
Ordinary Shares	Acquisiton	2015-09-10	1,133	$6.48	788,199	No	4	P	Direct
Ordinary Shares	Acquisiton	2015-09-09	34	$5.75	848,817	No	4	P	Direct
Ordinary Shares	Acquisiton	2015-09-10	1,222	$6.48	850,039	No	4	P	Direct
Ordinary Shares	Acquisiton	2015-09-09	35	$5.75	864,213	No	4	P	Direct
Ordinary Shares	Acquisiton	2015-09-10	1,245	$6.48	865,458	No	4	P	Direct
Ordinary Shares	Acquisiton	2015-09-09	5	$5.75	115,161	No	4	P	Indirect	See Footnotes
Ordinary Shares	Acquisiton	2015-09-10	166	$6.48	115,327	No	4	P	Indirect	See Footnotes
Ordinary Shares	Acquisiton	2015-09-09	9	$5.75	235,467	No	4	P	Indirect	See Footnotes
Ordinary Shares	Acquisiton	2015-09-10	339	$6.48	235,806	No	4	P	Indirect	See Footnotes
Ordinary Shares	Acquisiton	2015-09-09	8	$5.75	197,819	No	4	P	Indirect	See Footnotes
Ordinary Shares	Acquisiton	2015-09-10	285	$6.48	198,104	No	4	P	Indirect	See Footnotes
Ordinary Shares	Acquisiton	2015-09-09	78	$5.75	1,951,649	No	4	P	Indirect	See Footnotes
Ordinary Shares	Acquisiton	2015-09-10	2,810	$6.48	1,954,459	No	4	P	Indirect	See Footnotes
Ordinary Shares	Acquisiton	2015-09-09	100	$5.75	2,500,096	No	4	P	Indirect	See Footnotes
Ordinary Shares	Acquisiton	2015-09-10	3,600	$6.48	2,503,696	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Footnotes

The entities and individuals identified in the footnotes of this Form 4 may be deemed members of a group holding equity securities of the Issuer. The filing of this Form 4 and any statements included herein shall not be deemed to be an admission that such entities and individuals are members of such group.
Since the number of reporting persons that may be listed on a Form 4 is limited, the entities and individuals listed in these footnotes that are not reporting persons on this Form 4 are filing additional Forms 4 on the date hereof as reporting persons with respect to the securities described herein (the "Parallel Forms 4"). Information regarding these entities and individuals is included in this Form 4 for purposes of clarification and convenience only, and is duplicative of the information reported in the Parallel Forms 4.
The amount of securities shown in this row is owned directly by Akubra Investors, LLC ("Akubra").
The amount of securities shown in this row is owned directly by Bushranger Funding, LLC ("Bushranger").
The amount of securities shown in this row is owned directly by Ute Holdings, LLC ("Ute" and, together with Akubra and Bushranger, the "Farallon SPVs").
The amount of securities shown in this row is owned directly by the Farallon SPVs.
The members of Akubra are FCIP XR 2014, L.L.C. ("FCIP XR") and Noonday Special Situation Partners, L.P. ("NSSP") (each, a "Farallon Akubra Fund"). As the general partner of NSSP, NGP, L.L.C. (the "NSSP General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by NSSP as a Farallon Akubra Fund. The NSSP General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "'34 Act"), or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Akubra.
As the manager of the NSSP General Partner, Farallon Capital Management, L.L.C. (the "Management Company") may be deemed to be a beneficial owner of the Issuer's securities held by NSSP as a Farallon Akubra Fund. The Management Company disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Akubra.
The members of Bushranger are FCP XR 2014, L.L.C. ("FCP XR"), Farallon Capital Institutional Partners III, L.P. ("FCIP III"), and Farallon Capital AA Investors, L.P. ("FCAAI") (collectively, the "Farallon Bushranger Funds"). As the general partner of FCAAI, Farallon AA GP, L.L.C. (the "FCAAI General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FCAAI as a Farallon Bushranger Fund. The FCAAI General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Bushranger.
The members of Ute are FCOI II SS 2014, Ltd. ("FCOI II SS"), Farallon Capital Institutional Partners II, L.P. ("FCIP II"), and Farallon Special Situation Partners VI, L.P. ("FSSP VI") (collectively, the "Farallon Ute Funds"). As the general partner of FSSP VI, Farallon Partners GP VI, L.L.C. (the "FSSP VI General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FSSP VI as a Farallon Ute Fund. The FSSP VI General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, Ute.
As the general partner of each of (a) the sole member of FCIP XR, (b) the sole member of FCP XR, (c) FCIP III, (d) the sole member of FCOI II SS and (e) FCIP II, Farallon Partners, L.L.C. (the "Farallon General Partner") may be deemed to be a beneficial owner of the Issuer's securities indirectly held by FCIP XR as a Farallon Akubra Fund, FCP XR and FCIP III as Farallon Bushranger Funds, and FCOI II SS and FCIP II as Farallon Ute Funds. The Farallon General Partner disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act, or otherwise, except as to securities representing its pro rata interest in, and interest in the profits of, the Farallon SPVs.
Each of Michael B. Fisch, Richard B. Fried, Daniel J. Hirsch, David T. Kim, Monica R. Landry, Michael G. Linn, Thomas G. Roberts, Jr., John R. Warren and Mark C. Wehrly (collectively, the "Managing Members") and Andrew J. M. Spokes (the "Senior Managing Member"), as Managing Members or the Senior Managing Member, as the case may be, of both the Farallon General Partner and the Management Company, and as a manager or senior manager, as the case may be, of both the FCAAI General Partner and the FSSP VI General Partner, in each case with the power to exercise investment discretion, may be deemed to be a beneficial owner of the Issuer's securities held by the Farallon SPVs. Each of the Managing Members and the Senior Managing Member disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act or otherwise, except to the extent of his or her pecuniary interest, if any.
As a Managing Member of both the Farallon General Partner and the Management Company, and as a manager of both the FCAAI General Partner and the FSSP VI General Partner, in each case with the power to exercise investment discretion, Rajiv A. Patel ("Patel") may be deemed to be a beneficial owner of the Issuer's securities held by the Farallon SPVs. As a director of the Issuer, Patel is filing a separate Form 4 on the date hereof, which Form 4 reports that Patel may be deemed to be a beneficial owner of the Issuer's securities held by the Farallon SPVs. Patel disclaims any beneficial ownership of any of the Issuer's securities reported or noted herein for purposes of Section 16 of the '34 Act or otherwise, except to the extent of his pecuniary interest, if any.